Brian G. Drazba
2021 - MEI Pharma
In 2021, Brian G. Drazba earned a total compensation of $1.1M as Chief Financial Officer at MEI Pharma, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $138,047 |
|---|---|
| Option Awards | $554,300 |
| Salary | $406,020 |
| Total | $1,098,367 |
Drazba received $554.3K in option awards, accounting for 50% of the total pay in 2021.
Drazba also received $138K in non-equity incentive plan and $406K in salary.
Rankings
In 2021, Brian G. Drazba's compensation ranked 8,464th out of 12,415 executives tracked by ExecPay. In other words, Drazba earned more than 31.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,464 out of 12,415 | 32nd |
Division Manufacturing | 3,751 out of 5,505 | 32nd |
Major group Chemicals And Allied Products | 1,659 out of 2,375 | 30th |
Industry group Drugs | 1,477 out of 2,096 | 30th |
Industry Pharmaceutical Preparations | 1,100 out of 1,546 | 29th |
Source: SEC filing on October 28, 2021.
Drazba's colleagues
We found four more compensation records of executives who worked with Brian G. Drazba at MEI Pharma in 2021.